Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Justine Abella Ross"'
Publikováno v:
Cancer Medicine, Vol 11, Iss 1, Pp 21-27 (2022)
Abstract Background Immune checkpoint inhibitors (ICIs) are targeted cancer therapies regarded to have less toxicity than chemotherapy. Immune‐related adverse events (irAEs) of ICIs are well described in the literature but limited data exist on the
Externí odkaz:
https://doaj.org/article/b422d669ee74416dacf2daf094cb1f9b
Publikováno v:
Cancer Medicine, Vol 11, Iss 1, Pp 21-27 (2022)
Cancer Medicine
Cancer Medicine
Background Immune checkpoint inhibitors (ICIs) are targeted cancer therapies regarded to have less toxicity than chemotherapy. Immune‐related adverse events (irAEs) of ICIs are well described in the literature but limited data exist on their infect
Publikováno v:
Open Forum Infectious Diseases
Background Patients (pts) with newly diagnosed acute myeloid leukemia (AML) undergoing induction chemotherapy are at increased risk for invasive fungal infections (IFI). Guidelines recommend posaconazole prophylaxis (ppx), but use is precluded by int
Autor:
Justine Abella Ross, Bernard Tegtmeier, Deron Johnson, Deepa Nanayakkara, Alfredo Puing, Stephanie Ho, Randy Taplitz, Sanjeet Dadwal, Jana Dickter
Publikováno v:
Open Forum Infectious Diseases. 8:S140-S140
Background In patients (pts) with cancer, the risk of Pneumocystis jirovecii pneumonia (PJP) is a function of dose and duration of corticosteroids (CS), underlying immunodeficiency, and immunosuppressive drugs. Trimethoprim/sulfamethoxazole (TMP/SMX)